BackBioLight Life Sciences Overview

BioLight Life Sciences Total Liabilities

Track BioLight Life Sciences's total liabilities ($3.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.86M
↑ 25.54% YoYΔ $786000.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioLight Life Sciences Total Liabilities History

Loading

BioLight Life Sciences vs. peers: Total Liabilities Comparison

Loading

BioLight Life Sciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioLight Life Sciences (BOLT.TA) FAQ

BioLight Life Sciences posts a total liabilities of $3.9M as of June 2026. That compares with $3.1M in the prior-year period — up 25.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BioLight Life Sciences's total liabilities was $3.1M. The latest reading is $3.9M — a 25.5% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of BioLight Life Sciences's financial statement story. At $3.9M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BOLT.TA's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BioLight Life Sciences's other metric pages and overview cover the third.